Blood Cancer UK (Formerly Bloodwise) was one of the charity open Access fund (COAF) charities but now operates it’s own funds and structure for open access.
What is covered by the policy
Original research papers that have been accepted for publication in a peer reviewed journal, and that acknowledge Blood Cancer UK funding in whole or in part.
Encourage – and where an open access article processing charge is paid to the publisher, require – authors and publishers to licence research papers using the Creative Commons Attribution licence (CC-BY) so they may be freely copied and reused
Made available through Europe PubMed Central (Europe PMC) as soon as possible and, in any event, within six months of the journal publisher's official date of final publication.
Paying for Blood Cancer UK journal article publication
There is no need to fill in Oxford’s APC application form as unfortunately the Bodleian’s Open Access Payments Team is unable to process these payments centrally on behalf of researchers.
Please email BCUK at email@example.com when your manuscript has been accepted for publication to arrange for payment of an APC in journals that fulfil the following criteria:
A Blood Cancer UK grantholder or a researcher employed on the grant must be an author on the manuscript
Former grantholders can also apply within two years of the end date of their Blood Cancer UK grant
The article must acknowledge Blood Cancer UK as a funder
The Blood Cancer UK grant reference number(s) must be accurately cited on the manuscript
The proposed journal must support ‘Gold’ OA publishing with a Creative Commons Attribution (CC BY licence)
At the time of submitting a request, we expect the grantholder(s) and host institution to have explored alternative sources of OA support available
For publications arising from co-funded awards, our expectation is that funder(s) contribute equitably to support OA costs
APC payment cap
Blood Cancer UK have a cap on APC payments:
The maximum contribution we will make towards a single APC is £2,000.
(All quotations taken from Blood Cancer UK's policy page on 07/06/2023)